The logo of the British multinational pharmaceutical company GlaxoSmithKline on top of its headquarters in London on Feb. 2, 2022. Justin Tallis/AFP via Getty Images
U.S. regulators have expanded the approval for GlaxoSmithKline’s vaccine against respiratory syncytial virus (RSV), the company said March 13.
We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.
Read Full Article: https://www.theepochtimes.com/us/fda-expands-approval-of-gsks-respiratory-syncytial-virus-vaccine-5998416/?utm_source=partner&utm_campaign=whatfinger
